{
    "clinical_study": {
        "@rank": "151490", 
        "arm_group": {
            "arm_group_label": "ICD/ CRT-D therapy"
        }, 
        "brief_summary": {
            "textblock": "This clinical investigation is designed to confirm the safety and efficacy of the TD01 ICD\n      lead."
        }, 
        "brief_title": "TD01 Master Study (Safety and Efficacy Study)", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "ICD/CRT-D Indication", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Meet standard indication for ICD/CRT-D therapy\n\n          -  First ICD/CRT-D implantation or upgrade from pacemaker\n\n          -  Duly signed informed consent form\n\n          -  Willing to participate for the whole study duration\n\n          -  Patient accepts Home Monitoring concept and is able to activate and use the\n             CardioMessenger\n\n          -  Patient has a legal capacity and ability to consent\n\n        Exclusion Criteria:\n\n          -  Meet a standard contraindication for an ICD/CRT-D therapy\n\n          -  Age < 18 years\n\n          -  Pregnant or breast-feeding\n\n          -  Cardiac surgery planned within the next six months\n\n          -  Enrollment in another cardiac clinical investiga-tion with active treatment arm\n\n          -  Mechanical tricuspid valve prosthesis or severe tricuspid valve disease\n\n          -  Known dexamethasone acetate intolerance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The patients selected for the investigation should be from the investigator's general\n        patient population according to the inclusion and exclusion criteria."
            }
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02087189", 
            "org_study_id": "TA107"
        }, 
        "intervention": {
            "arm_group_label": "ICD/ CRT-D therapy", 
            "intervention_name": "First ICD/CRT-D implantation or upgrade from pacemaker", 
            "intervention_type": "Device", 
            "other_name": [
                "TD01 (investigational device)", 
                "Lumax 540, 640 or 740: VR-T, DR-T or HF-T or", 
                "Ilesto 5 or Ilesto 7 DF-1: VR-T, DR-T or HF-T or", 
                "Iforia 3, 5 or Iforia 7 DF-1: VR-T, DR-T or HF-T", 
                "(or successor)", 
                "Free choice of additional RA and/or LV lead (if applicable)"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "ICD, CRT-D, lead", 
        "lastchanged_date": "March 12, 2014", 
        "number_of_groups": "1", 
        "official_title": "TD01 Master Study (Safety and Efficacy Study)", 
        "overall_contact": {
            "email": "torsten.kallert@biotronik.com", 
            "last_name": "Torsten Kallert", 
            "phone": "+49 30 68905", 
            "phone_ext": "1266"
        }, 
        "overall_official": {
            "affiliation": "Medizinische Klinik II, Klinikum Frankfurt (Oder) GmbH, Muellroser Chaussee 7, 15236 Frankfurt (Oder) Germany", 
            "last_name": "Oliver Gunkel, Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Non-inferiority of the pacing threshold compared to Linox TD", 
                "measure": "Pacing threshold with TD01", 
                "safety_issue": "No", 
                "time_frame": "3 month follow-up"
            }, 
            {
                "description": "Non-inferiority of the sensing amplitude compared to Linox TD", 
                "measure": "Sensing amplitude with TD01", 
                "safety_issue": "No", 
                "time_frame": "3 month follow-up"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02087189"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "SADE-free rate related to TD01", 
            "measure": "SADE-free rate related to TD01", 
            "safety_issue": "Yes", 
            "time_frame": "3 month follow-up"
        }, 
        "source": "Biotronik SE & Co. KG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biotronik SE & Co. KG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}